TrialRheumatology international2021

Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial.

Dženan Mašić et al.PubMed ↗Publisher ↗

No numbers read from the abstract.